Mark V. Mishra, MD

  • Associate Professor of Radiation Oncology

Mark V. Mishra, MD

Specialties:

  • Genitourinary Radiation Oncology

  • Neurologic Radiation Oncology

  • Breast Radiation Oncology

  • Radiation Oncology

Available for Telemedicine Visits

About Mark V. Mishra, MD

Toggle accordion item

Mark Mishra, MD, is an Associate Professor of Radiation Oncology at the University of Maryland School of Medicine who focuses on treatment of patients with tumors of the central nervous system and genitourinary tract, as well as breast cancer. He serves as the Director of Clinical Research for the Department of Radiation Oncology, as Vice-Chair of the Greenebaum Comprehensive Cancer Center’s Clinical Research Committee, and as Chair of Radiation Oncology Executive Academic and Advisory Council. 

He is a graduate of the University of Cincinnati College of Medicine and completed his residency in Radiation Oncology at Thomas Jefferson University, where he served as chief resident. He completed a clinical research fellowship in the NIH Clinical Research Training Program and also completed the Program in Clinical Effectiveness at the Harvard T.H. Chan School of Public Health. As Director of Radiation Oncology Clinical Research, Dr. Mishra oversees all clinical trial activities for Radiation Oncology at UMGCCC and at affiliated practices across the state of Maryland. He serves as the UMGCCC Voting-Member Contact PI for NRG Oncology. 

Dr. Mishra’s research focus is centered on evaluating the comparative- and cost-effectiveness of new and complex radiation technologies, such as proton beam therapy, as well as evaluating novel uses of radiation therapy alone or in combination with other therapies. He has received the American Society of Radiation Oncology (ASTRO) Comparative Effectiveness Grant and is the Comparative Effectiveness Co-Chair for 2 recently activated national phase III studies (NRG BN009 and NRG CC009) focused on identifying new treatment approaches for brain metastases. Dr. Mishra is also the PI for 2 investigator-initiated trials at UMGCCC evaluating the efficacy of combining laser interstitial thermal therapy with radiation for patients with a recurrent glioma as well as patients with a newly diagnosed unresectable glioma. 

As a result of his clinical trial work at UMGCCC he has been named as a recipient of the National Cancer Institute Cancer Center Investigator Team Leadership Award. His research has been supported by NIH, the Patient Centered Outcomes Research Institute (PCORI), ASTRO, and the Keep Punching Foundation. He has served as a member of the PCORI Patient Engagement Advisory Panel and on national level committees for ASTRO, the American College of Radiology, and the American Board of Radiology. His research has resulted in more than 75 peer-reviewed publications with more than 1,100 citations to date. He has been recognized as a ‘Top Doctor’ by Baltimore Magazine.
 

Gender: Male

Language(s): English

Affiliation(s):

  • UM Upper Chesapeake Health

  • UM Baltimore Washington Medical Center

  • University of Maryland Medical Center

  • Member of UM Faculty Physicians, Inc.

X

In case of emergency, please call 911

Maryland Proton Treatment Center

850 West Baltimore Street
Baltimore, MD 21201
Get Directions

PH: 410-369-5221

PH: 410-369-5221

FAX: 410-369-0870

University of Maryland Radiation Oncology Associates, PA

22 South Greene Street
Gudelsky Basement
Suite GGK0107
Baltimore, MD 21201
Get Directions

PH: 410-328-6080

PH: 410-328-6080

FAX: 410-328-6911